Ligand Pharmaceuticals (LGND) Gross Profit (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ligand Pharmaceuticals | 4.61 Bn | 3.83 Bn | 48.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.51% |
| Dec 31, 2025 | -49.24% |
| Sep 30, 2025 | 149.69% |
| Jun 30, 2025 | 10.46% |
| Mar 31, 2025 | 1.27% |
| Dec 31, 2024 | -19.02% |
| Sep 30, 2024 | 27.80% |
| Jun 30, 2024 | 37.48% |
| Mar 31, 2024 | 6.18% |
| Dec 31, 2023 | -9.95% |
| Sep 30, 2023 | 18.97% |
| Jun 30, 2023 | -38.66% |
| Mar 31, 2023 | 39.95% |
| Dec 31, 2022 | -36.17% |
| Sep 30, 2022 | 19.34% |
| Jun 30, 2022 | 18.69% |
| Mar 31, 2022 | -28.37% |
| Dec 31, 2021 | -7.93% |
| Sep 30, 2021 | -0.03% |
| Jun 30, 2021 | 25.55% |
| Mar 31, 2021 | -34.01% |
| Dec 31, 2020 | 64.11% |
| Sep 30, 2020 | 5.09% |
| Jun 30, 2020 | 18.60% |
| Mar 31, 2020 | 13.61% |
| Dec 31, 2019 | 15.72% |
| Sep 30, 2019 | -4.08% |
| Jun 30, 2019 | -43.01% |
| Mar 31, 2019 | -30.03% |
| Dec 31, 2018 | 28.12% |
| Sep 30, 2018 | -50.28% |
| Jun 30, 2018 | 60.58% |
| Mar 31, 2018 | -4.29% |
| Dec 31, 2017 | 33.68% |
| Sep 30, 2017 | -51.45% |
| Jun 30, 2017 | 59.70% |
| Mar 31, 2017 | 58.17% |
| Dec 31, 2016 | 71.13% |
| Sep 30, 2016 | 9.68% |
| Jun 30, 2016 | -34.48% |
| Mar 31, 2016 | 41.28% |
| Dec 31, 2015 | 23.45% |
| Sep 30, 2015 | 4.00% |
| Jun 30, 2015 | 16.93% |
| Mar 31, 2015 | -28.79% |
| Dec 31, 2014 | 40.95% |
| Sep 30, 2014 | 43.04% |
| Jun 30, 2014 | -30.24% |
| Mar 31, 2014 | 0.64% |
| Dec 31, 2013 | 28.22% |
| Sep 30, 2013 | 25.11% |
| Jun 30, 2013 | -23.86% |
| Mar 31, 2013 | -2.82% |
| Dec 31, 2012 | 98.65% |
| Sep 30, 2012 | 7.25% |
| Jun 30, 2012 | -3.17% |
| Mar 31, 2012 | -49.62% |
| Dec 31, 2011 | 115.94% |
| Sep 30, 2011 | -13.73% |
| Jun 30, 2011 | 73.24% |